Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 Oct 26;64(5):10.1002/pbc.26303. doi: 10.1002/pbc.26303

TABLE 2.

Demographics, presentation, and outcome of patients

SCAMP-1
N=40
SCAMP-2
N=31
p-value

Median Age in years (range) 3.8 (1.3–13.8) 7.8 (1.3–14.3) 0.06

Female (%) 18 (45%) 16 (52%) 0.63

Initial platelet count (109 cells/uL)
(median, IQR)
7 (5– 10.5) 6 (4–12) 0.86

Initial Bleeding Score n (%) 0.093
  ≤Grade 2 17 (43%) 20 (65%)
  Grade 3 23 (56%) 11 (35%)

SCAMP Recommended
Observation pathway
17 (43%) 27 (81%) 0.0002

Observation Rate 16 (40%) 23 (74%) 0.007

Patients hospitalized within 6
months of diagnosis*
4/35 (11%) 2/25 (8%) 1.0
    Reasons for Admission Medication
administration (2)
Parental anxiety
(1)
Distance from the
hospital (1)
Medication
administration (1)
Observation for
bleeding (1)
*

Some patients exited the SCAMP earlier or were lost to follow up.